Get 40% Off
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list

Stock Market News For October 12, 2016

Published 10/11/2016, 10:10 PM
Updated 07/09/2023, 06:31 AM

Disappointing start to the third quarter earnings season weighed on benchmarks on Tuesday. Alcoa unofficially kicked off the earnings season, with its earnings and revenues falling short of expectations, while a retreat in oil prices also hurt sentiments. Increase in production levels by OPEC coupled with a stronger dollar negatively impacted oil prices. The Nasdaq, on the other hand, was dragged down by declines in biotech stocks.

For a look at the issues currently facing the markets, make sure to read today’s Ahead of Wall Street article.

The Dow Jones Industrial Average (DJI) decreased 1.1%, to close at 18,128.66. The S&P 500 dropped 1.2% to close at 2,136.73. The tech-laden Nasdaq Composite Index closed at 5,246.79, losing 1.5%. The fear-gauge CBOE Volatility Index (VIX) surged 17.6% to settle at 15.74. A total of around 6.7 billion shares were traded on Tuesday, slightly lower than the last 20-session average of 6.8 billion shares. Decliners outpaced advancing stocks on the NYSE. For 85% stocks that declined, 13% advanced.

Disappointing Start to Q3 Earnings Season

Stocks were battered on Tuesday, thanks to a discouraging start to the third-quarter earnings season. Alcoa Inc (NYSE:AA).’s (AA) shares tanked 11% after the company’s earnings and revenue grew less-than-expected. This was the biggest daily percentage drop for the stock since Aug. 8, 2011. Earnings per share for the company in the third quarter were 32 cents, less than the Zacks Consensus Estimate of 34 cents. Revenues of $5,213 million also trailed the Zacks Consensus Estimate of $5,334 million.

Alcoa also trimmed its revenue target for this year. For its Global Rolled Products, the company now expects revenues of $4.8 billion to $5 billion for 2016, down from $5 billion to $5.2 billion it expected earlier. For its Engineered Products and Solutions the company expects sales of $5.6 billion to $5.8 billion for 2016, down from its earlier view of $5.9 billion to $6.1 billion.

The aluminum giant, likewise, sees revenues from the Transportation and Construction Solutions unit in the band of $1.7 billion to $1.8 billion, down from the prior view of $2.1 billion (read more: Alcoa Misses Q3 Earnings, Sales Estimates; Shares Tank).

In the third quarter, earnings growth is expected to take a beating, which will be the sixth quarter in a row of earnings declines for the S&P 500 index. Total earnings for the index are expected to be down 3% from the same period last year on 1.2% higher revenues (read more: Will Earnings Growth Resume After the Q3 Earnings Season?).

Oil Prices Tumble

A retreat in oil prices also dented investors’ sentiment. The International Energy Agency said that oil production by the Organization of the Petroleum Exporting Countries (OPEC) rose to record highs in September, which eventually dragged oil prices down. The top energy watchdog said that OPEC crude output rose by 160,000 barrels a day (bpd) to a record 33.64 million bpd last month.

A stronger dollar too had a negative impact on oil prices. The dollar strengthened on rising expectations of an imminent rate hike. The WSJ Dollar Index, which measures the dollar against a basket of 16 other currencies, rose 0.8% yesterday. On the other hand, WTI crude declined 1.1% to $50.79 per barrel, while Brent crude slipped 1.4% to $52.41 a barrel.

Biotechs Weigh on Nasdaq

Broad based selloff among biotech stocks adversely affected the Nasdaq. The iShares Nasdaq Biotechnology (IBB) declined 3.8%, while the broader Health Care Select Sector SPDR ETF (NYSE:XLV) fell by 2.5%, the highest among the S&P 500 sectors.

Key biotech stocks such as Biogen (NASDAQ:BIIB) Inc. (BIIB) and Amgen Inc (NASDAQ:AMGN). (AMGN) decreased 2.1% and 2.4%, respectively. Both the two companies possess a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Stocks That Made Headlines

Dover Cuts 2016 EPS & Revenue Outlook, Shares Fall

Dover Corporation (DOV) trimmed its full-year 2016 EPS and revenue outlook. (Read More)

Rent-A-Center Stock Tumbles on Bleak Q3 Preliminary Results

Rent-A-Center, Inc. (RCII) issued dismal preliminary guidance for third-quarter 2016. (Read More)

Gibraltar Buys Nexus for $25M, Boosts Greenhouse Business

Gibraltar Industries, Inc. (ROCK) reinforced its position in the United States commercial greenhouse market, by acquiring Nexus Corporation (‘Nexus’) for $25 million in an all-cash deal. (Read More)

International Flavors Completes Acquisition of David Michael

International Flavors & Fragrances Inc. (IFF) recently announced that it has successfully completed the acquisition of Philadelphia, PA-based David Michael & Company, Incorporated. (Read More)

Comcast (NASDAQ:CMCSA
) Coughs Up $2.3M to Settle False Billing Charges

Comcast Corporation (CMCSA) has agreed to pay $2.3 million to the Federal Communications Commission as a settlement for its unlawful billing practices. (Read More)

Looking for Ideas with Even Greater Upside?

Today's investment ideas are short-term, directly based on our proven 1 to 3 month indicator. In addition, I invite you to consider our long-term opportunities. These rare trades look to start fast with strong Zacks Ranks, but carry through with double and triple-digit profit potential. Starting now, you can look inside our home run, value, and stocks under $10 portfolios, plus more. Click here for a peek at this private information >>



ALCOA INC (AA): Free Stock Analysis Report

BIOGEN INC (BIIB): Free Stock Analysis Report

AMGEN INC (AMGN): Free Stock Analysis Report

DOVER CORP (DOV): Free Stock Analysis Report

RENT-A-CENTER (RCII): Free Stock Analysis Report

GIBRALTAR INDUS (ROCK): Free Stock Analysis Report

INTL F & F (IFF): Free Stock Analysis Report

COMCAST CORP A (CMCSA): Free Stock Analysis Report

Original post

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.